ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Determinants of Late Acute Rejection in Pediatric & Adolescent Kidney Transplant Recipients

L. Eid, S. Tuchman, A. Moudgil

Pediatric Nephrology, Children's National Medical Center, Washington, DC

Meeting: 2013 American Transplant Congress

Abstract number: 390

Background: Long-term graft function has not kept pace with short-term graft survival in children. Late Acute Rejection (LAR) episodes are in part responsible for the lack of long-term graft survival. The risk factors for LAR in pediatric & adolescent in kidney transplant (Tx) recipients are not well defined

Objective: To identify the determinants for LAR in pediatric & adolescent kidney Tx recipients

Design/Methods: A retrospective analysis of pediatric & adolescent kidney Tx recipients ≤21 yrs of age at the time of Tx between July 1,2005 & June 30,2011 with at least 1 yr follow-up. Of 73 Tx recipients, 64 were included in the analysis. 9 recipients were excluded for either graft loss or early acute rejection(occurring ≤6 months post-Tx). The included patients were divided into 2 cohorts; control group-41 & LAR group-23 patients(≥6 months at time of rejection). Donor-Specific Antibodies (DSA) were obtained at the time of clinical suspicion of LAR.

Results: LAR was diagnosed by clinical & histological criteria in 23(35.9%) Tx recipients. Mean age at Tx was not different in the groups(13.3±5.2 yrs in controls vs. 12.6±5.6 yrs in LAR). Mean age at the time of LAR was 14.7±4.8 yrs with 60.8% ≥12 yrs of age. Mean follow-up period was 31.2(3.9-79) months. Significant clinical & demographic factors that were associated with LAR by univariate analyses in the cohort are shown below.

Significant Variables LAR Control
Total n 64 (%) 23 (35.9) 95% CI 41 (64.1) 95% CI p
DSA; 26 (40.6) 15 (65.2) 0.22-0.63 11 (26.8) 0.33-0.24 0.003
Delayed Graft Function (DGF); 16 (25) 10 (43.4) 0.45-0.84 6 (14.6) 0.13-0.40 0.0096
Non-adherence; 11 (17.2) 8 (34.8) 0.15-0.54 3 (7.3) 0.008-0.14 0.0043
Coefficient Variation (CV)% of Tacrolimus (TAC) Levels 41.8 34.2-49.4 34.6 31.7-37.4 0.03

Other variables with p<0.10 in univariate analyses were included in multivariate logistic-regression analyses with the odds ratio of each variable shown below.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Eid L, Tuchman S, Moudgil A. Determinants of Late Acute Rejection in Pediatric & Adolescent Kidney Transplant Recipients [abstract]. Am J Transplant. 2013; 13 (suppl 5). https://atcmeetingabstracts.com/abstract/determinants-of-late-acute-rejection-in-pediatric-adolescent-kidney-transplant-recipients/. Accessed May 14, 2025.

« Back to 2013 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences

Clinical Characteristics OR SD (95% CI) p
DSA 15 12.9 ( 2.7-81.5) 0.002
DGF 14.4 13.1 (2.4-85.6) 0.003
CV% of TAC Levels 1.06 0.03 (0.99-1.1) 0.057
Non-adherence 4.4 5.3 (0.39-47.6) 0.227
HLA DR-Mismatch(0 vs. Others) 2.2 3.1 (0.13-34.1) 0.580
Age at Tx ≥12 yrs 0.89 0.66 (0.20-3.8) 0.880
Race(A-A vs. Others) 1.6